Bundamedik Tbk vs Millennium Pharmacon International Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Millennium Pharmacon International Tbk. trades at Rp181 (market cap 230.59B, 12.1K 24h volume). The key difference: Bundamedik Tbk is far larger — about 6.5× Millennium Pharmacon International Tbk.'s market cap, and Bundamedik Tbk is more actively traded (536.7K versus 12.1K). Which is the better fit depends on your goals.
| BMHS | SDPC | |
|---|---|---|
Market Cap | 1.51T | 230.59B |
Volume | 536.7K | 12.1K |
Lot | 5.37K | 121 |
Turnover | 93.41M | 2.2M |
Average Price | 174.05 | 181.48 |
Value | 93.41M | 2.2M |
Indicative Equilibrium Price | 176 | — |
Indicative Equilibrium Volume | 100 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Millennium Pharmacon International Tbk (the Company) was established on October 20th, 1952 under the name N.V. Perusahaan Dagang SOEDARPO CORPORATION. On July 29th, 1997, the Extraordinary Shareholders meeting held by the Company has approved the sale of assets and of the whole share participation on the Company in PT Praweda Ciptakarsa Informatika and PT Sumber Daya Praweda Informatika. In order to strengthen its equity and settle the foreign currently loan, the Company has conducted its first Right Issue and has submitted the registration statement on May 8th, 2000 to the Capital Advisory Board (BAPEPAM). The Company started its operations on October 20, 1952. The name was changed from previous name PT NVPD Soedarpo Corporation.
Read more on SDPC →